Telmisartan Lowers Elevated Blood Pressure in Psoriatic Mice without Attenuating Vascular Dysfunction and Inflammation.

Int J Mol Sci · 2019 · PMC6747395 · PMID 31480330

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

After four weeks of telmisartan treatment, we found a highly significant decrease of systolic blood pressure in K14-IL-17A ind/+ and IL-17A ind/+ control mice compared to sham-treated littermates ( Figure 1 b).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.